Dr. Omkar Marathe, MD

Internal Medicine Lakewood, CA Male
NPI: 1982989836
Total Payments
$41,508
2024 Payments
$4,068
Companies
91
Transactions
1,314
Medicare Patients
1,953
Medicare Billing
$328,888

Payment Breakdown by Category

Food & Beverage$25,962 (62.5%)
Research$10,925 (26.3%)
Consulting$2,543 (6.1%)
Education$1,497 (3.6%)
Other$581.83 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $25,962 1,261 62.5%
Unspecified $10,925 6 26.3%
Consulting Fee $2,543 2 6.1%
Education $1,497 39 3.6%
Long term medical supply or device loan $581.83 6 1.4%

Payments by Type

General
$30,583
1,308 transactions
Research
$10,925
6 transactions

Top Paying Companies

Company Total Records Latest Year
ONQUALITY PHARMACEUTICALS (USA) LLC $10,925 6 $0 (2023)
AstraZeneca Pharmaceuticals LP $3,259 61 $0 (2024)
Novartis Pharmaceuticals Corporation $2,763 113 $0 (2024)
E.R. Squibb & Sons, L.L.C. $1,693 137 $0 (2024)
PFIZER INC. $1,500 86 $0 (2024)
Incyte Corporation $1,342 45 $0 (2024)
Celgene Corporation $1,306 62 $0 (2024)
Merck Sharp & Dohme LLC $1,110 55 $0 (2024)
Astellas Pharma US Inc $1,011 38 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $866.85 41 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,068 164 Novartis Pharmaceuticals Corporation ($354.16)
2023 $8,416 203 AstraZeneca Pharmaceuticals LP ($2,082)
2022 $6,508 207 ONQUALITY PHARMACEUTICALS (USA) LLC ($1,700)
2021 $12,630 222 ONQUALITY PHARMACEUTICALS (USA) LLC ($8,475)
2020 $3,160 155 E.R. Squibb & Sons, L.L.C. ($258.88)
2019 $2,803 142 Genentech USA, Inc. ($268.01)
2018 $1,962 108 E.R. Squibb & Sons, L.L.C. ($220.83)
2017 $1,961 113 Novartis Pharmaceuticals Corporation ($237.79)

All Payment Transactions

1,314 individual payment records from CMS Open Payments — Page 1 of 53

Date Company Product Nature Form Amount Type
12/27/2024 Janssen Biotech, Inc. CARVYKTI (Drug) Food and Beverage In-kind items and services $24.37 General
Category: Oncology
12/18/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $21.80 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
12/17/2024 Daiichi Sankyo Inc. Vanflyta (Drug) Food and Beverage In-kind items and services $27.86 General
Category: ONCOLOGY
12/16/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $29.47 General
Category: ONCOLOGY
12/12/2024 Takeda Pharmaceuticals U.S.A., Inc. FRUZAQLA (Drug) Food and Beverage In-kind items and services $28.56 General
Category: ONCOLOGY
12/10/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $19.71 General
Category: ONCOLOGY
12/10/2024 AstraZeneca Pharmaceuticals LP — Food and Beverage In-kind items and services $17.40 General
12/09/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $28.46 General
Category: ONCOLOGY
12/09/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI, TUKYSA Food and Beverage In-kind items and services $15.33 General
Category: ONCOLOGY
12/05/2024 JAZZ PHARMACEUTICALS INC. ZIIHERA (Drug) Food and Beverage In-kind items and services $30.02 General
Category: HEMATOLOGY/ONCOLOGY
12/03/2024 PFIZER INC. BOSULIF (Drug), ELREXFIO, ADCETRIS Food and Beverage In-kind items and services $28.86 General
Category: METABOLIC DISEASE;ONCOLOGY
12/02/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $22.47 General
Category: Hematology
12/02/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $2.43 General
Category: Hematology
11/22/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $15.10 General
Category: Immunology
11/19/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $16.61 General
Category: Acute Myeloid Leukemia
11/18/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $23.41 General
11/15/2024 Takeda Pharmaceuticals U.S.A., Inc. ALUNBRIG (Drug) Food and Beverage In-kind items and services $30.19 General
Category: ONCOLOGY
11/12/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $33.13 General
Category: Oncology
11/12/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $27.76 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
11/07/2024 TAIHO ONCOLOGY, INC. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $28.06 General
Category: Oncology
11/05/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $21.87 General
Category: ONCOLOGY
11/04/2024 Lilly USA, LLC VERZENIO (Drug), RETEVMO, JAYPIRCA Food and Beverage In-kind items and services $21.44 General
Category: Oncology
10/31/2024 Astellas Pharma US Inc Vyloy (Drug) Food and Beverage In-kind items and services $13.98 General
Category: Oncology
10/29/2024 Agios Pharmaceuticals, Inc. PYRUKYND (Drug) Food and Beverage In-kind items and services $29.95 General
Category: Genetically Defined Disease
10/28/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $32.93 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
123…53»

Research Studies & Clinical Trials

Study Name Company Amount Records
A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients (NOVA-II) ONQUALITY PHARMACEUTICALS (USA) LLC $9,975 5
Unpublished research ONQUALITY PHARMACEUTICALS (USA) LLC $950.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 457 2,662 $200,895 $79,496
2022 19 507 3,903 $211,339 $79,905
2021 15 445 1,941 $212,614 $91,880
2020 21 544 2,261 $212,669 $77,607
Total Patients
1,953
Total Services
10,767
Medicare Billing
$328,888
Procedure Codes
74

All Medicare Procedures & Services

74 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 98 208 $56,523 $20,710 36.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 30 166 $38,700 $16,895 43.7%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 27 95 $29,118 $11,605 39.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 24 32 $11,380 $4,741 41.7%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 54 82 $15,889 $4,646 29.2%
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services Office 2023 13 41 $5,740 $3,606 62.8%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2023 12 51 $7,699 $3,079 40.0%
36591 Collection of blood sample from implanted device Office 2023 20 101 $6,234 $2,459 39.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 13 14 $5,127 $2,203 43.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 26 28 $5,683 $2,156 37.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $5,121 $1,944 38.0%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 18 69 $4,655 $1,822 39.1%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 13 25 $3,594 $1,440 40.1%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 12 51 $3,282 $1,327 40.4%
96375 Injection of additional new drug or substance into vein Office 2023 12 31 $1,130 $438.43 38.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 24 35 $412.23 $255.60 62.0%
J2405 Injection, ondansetron hydrochloride, per 1 mg Office 2023 15 1,040 $335.72 $74.31 22.1%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 12 520 $126.10 $48.08 38.1%
J1200 Injection, diphenhydramine hcl, up to 50 mg Office 2023 20 59 $146.71 $46.94 32.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 100 200 $56,925 $20,357 35.8%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 30 126 $40,908 $16,196 39.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 28 121 $26,499 $10,678 40.3%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 51 95 $19,044 $6,548 34.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 29 37 $15,688 $6,259 39.9%
96417 Administration of additional new drug or substance into vein, 1 hour or less Office 2022 11 59 $9,322 $3,716 39.9%
123»

About Dr. Omkar Marathe, MD

Dr. Omkar Marathe, MD is a Internal Medicine healthcare provider based in Lakewood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982989836.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omkar Marathe, MD has received a total of $41,508 in payments from pharmaceutical and medical device companies, with $4,068 received in 2024. These payments were reported across 1,314 transactions from 91 companies. The most common payment nature is "Food and Beverage" ($25,962).

As a Medicare-enrolled provider, Marathe has provided services to 1,953 Medicare beneficiaries, totaling 10,767 services with total Medicare billing of $328,888. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hematology & Oncology
  • Location Lakewood, CA
  • Active Since 10/11/2011
  • Last Updated 11/19/2018
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1982989836

Products in Payments

  • TAGRISSO (Drug) $2,235
  • OPDIVO (Biological) $1,400
  • KISQALI (Drug) $1,254
  • KEYTRUDA (Biological) $990.84
  • Lenvima (Drug) $677.66
  • NINLARO (Drug) $633.54
  • REBLOZYL (Biological) $505.69
  • CABOMETYX (Drug) $472.35
  • JAKAFI (Drug) $455.83
  • Pomalyst (Drug) $449.38
  • MONJUVI (Drug) $430.96
  • INLYTA (Drug) $401.78
  • Enhertu (Drug) $397.16
  • BOSULIF (Drug) $360.78
  • ZEJULA (Drug) $350.00
  • GILOTRIF (Drug) $349.72
  • SARCLISA (Biological) $343.71
  • XPOVIO (Drug) $341.33
  • LYNPARZA (Drug) $339.26
  • Stivarga (Drug) $326.72

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Lakewood

William Bensinger, Md, MD

Internal Medicine — Payments: $1.8M

Internal Medicine $1.8M

Dr. Howard Uderman, M.d, M.D

Internal Medicine — Payments: $947,366

Internal Medicine $947,366

Dr. Kenneth Cohen, M.d, M.D

Internal Medicine — Payments: $269,079

Internal Medicine $269,079

Joseph Morelos, D.o, D.O

Internal Medicine — Payments: $32,524

Internal Medicine $32,524

Sarah Easaw, Md Llc, MD LLC

Internal Medicine — Payments: $28,719

Internal Medicine $28,719

Dr. Norman Gray, Md, MD

Internal Medicine — Payments: $17,345

Internal Medicine $17,345